N Eleftheriadis

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
    Athanasios Fassas
    Cell and Gene Therapy Unit, Department of Hematology and Bone Marrow Transplantation, The George Papanicolaou Hospital, Thessaloniki, Greece
    Autoimmunity 41:601-10. 2008
  2. ncbi The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
    Athanasios Fassas
    Department of Hematology and Bone Marrow Transplant Unit, George Papanicolaou Hospital, Thessaloniki, Greece
    Leuk Lymphoma 46:795-802. 2005
  3. ncbi Stem cell transplantation for autoimmune disorders. Multiple sclerosis
    Athanasios Fassas
    Bone Marrow Transplantation Unit, Department of Haematology, George Papanicolaou Hospital, 57010 Exokhi, Thessaloniki, Greece
    Best Pract Res Clin Haematol 17:247-62. 2004
  4. ncbi Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience
    Athanasios Fassas
    Department of Hematology and Bone Marrow Transplantation Unit, George Papanicolaou Hospital, 57010 Exokhi, Thessaloniki, Greece
    J Neurol Sci 223:53-8. 2004
  5. ncbi High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis
    Athanasios Fassas
    Department of Hematology, Aristotle University Medical School, George Papanicolaou Hospital, Thessaloniki, Greece
    J Hematother Stem Cell Res 12:701-11. 2003
  6. ncbi Stem cell transplantation for multiple sclerosis: what is the evidence?
    Athanasios Fassas
    Hematology Department and BMT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
    Blood Rev 17:233-40. 2003
  7. ncbi Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study
    A Fassas
    George Papanicolaou General Hospital, Dpt Hematology, 57010 Thessaloniki, Greece
    J Neurol 249:1088-97. 2002
  8. ncbi Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study
    A Fassas
    Department of Haematology, George Papanicolaou General Hospital, Exokhi, Thessaloniki, Greece
    Br J Haematol 116:308-15. 2002
  9. ncbi Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy
    A Fassas
    Department of Hematology, The George Papanicolaou General Hospital, Thessaloniki, Greece
    J Clin Immunol 20:24-30. 2000
  10. ncbi Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status
    A Lazaridou
    Department of Hematology, Theagenio Cancer Center of Thessaloniki, Greece
    Leuk Lymphoma 36:503-12. 2000

Detail Information

Publications11

  1. ncbi Autologous hemopoietic stem cell transplantation for multiple sclerosis: is it worthwile?
    Athanasios Fassas
    Cell and Gene Therapy Unit, Department of Hematology and Bone Marrow Transplantation, The George Papanicolaou Hospital, Thessaloniki, Greece
    Autoimmunity 41:601-10. 2008
    ....
  2. ncbi The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
    Athanasios Fassas
    Department of Hematology and Bone Marrow Transplant Unit, George Papanicolaou Hospital, Thessaloniki, Greece
    Leuk Lymphoma 46:795-802. 2005
    ..Two comparative trials are currently active in AML patients, one in children and another in the elderly, run by the international BFM and GIMEMA groups, respectively...
  3. ncbi Stem cell transplantation for autoimmune disorders. Multiple sclerosis
    Athanasios Fassas
    Bone Marrow Transplantation Unit, Department of Haematology, George Papanicolaou Hospital, 57010 Exokhi, Thessaloniki, Greece
    Best Pract Res Clin Haematol 17:247-62. 2004
    ..The clinical effect of transplantation remains to be demonstrated in comparative studies...
  4. ncbi Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: rationale and clinical experience
    Athanasios Fassas
    Department of Hematology and Bone Marrow Transplantation Unit, George Papanicolaou Hospital, 57010 Exokhi, Thessaloniki, Greece
    J Neurol Sci 223:53-8. 2004
    ..e., mitoxantrone, seems justified and is under way...
  5. ncbi High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis
    Athanasios Fassas
    Department of Hematology, Aristotle University Medical School, George Papanicolaou Hospital, Thessaloniki, Greece
    J Hematother Stem Cell Res 12:701-11. 2003
    ..e., mitoxantrone, and in about 5 years we should know whether transplantation offers more than the benefit of a transient immunosuppressive effect...
  6. ncbi Stem cell transplantation for multiple sclerosis: what is the evidence?
    Athanasios Fassas
    Hematology Department and BMT Unit, George Papanicolaou Hospital, Thessaloniki, Greece
    Blood Rev 17:233-40. 2003
    ..A randomized trial is now launched by the EBMT to compare ASCT to mitoxantrone, currently regarded as one of the best available treatments, in properly selected patients having high chance of response at minimal mortality risk...
  7. ncbi Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study
    A Fassas
    George Papanicolaou General Hospital, Dpt Hematology, 57010 Thessaloniki, Greece
    J Neurol 249:1088-97. 2002
    ....
  8. ncbi Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study
    A Fassas
    Department of Haematology, George Papanicolaou General Hospital, Exokhi, Thessaloniki, Greece
    Br J Haematol 116:308-15. 2002
    ..At this dose schedule, interestingly high remission rates were achieved, justifying further evaluation of DaunoXome for the treatment of relapsed or refractory AML patients...
  9. ncbi Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy
    A Fassas
    Department of Hematology, The George Papanicolaou General Hospital, Thessaloniki, Greece
    J Clin Immunol 20:24-30. 2000
    ....
  10. ncbi Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status
    A Lazaridou
    Department of Hematology, Theagenio Cancer Center of Thessaloniki, Greece
    Leuk Lymphoma 36:503-12. 2000
    ..A larger group of patients studied in a prospective manner will better clarify these issues in the future...
  11. ncbi Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate
    K Pistevou-Gombaki
    Dept. of Radiation Oncology, AHEPA Hospital, Aristotles University of Thessaloniki, Greece
    J Exp Clin Cancer Res 21:429-32. 2002
    ....